Inflammatory mediators induced by amyloid-beta in the retina and RPE In Vivo: Implications for inflammasome activation in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 3, 2013, Pages 2225-2237

  Liu, Ruozhou Tom ^a   Gao, Jiangyuan ^a   Cao, Sijia ^a   Sandhu, Navroop ^b   Cui, Jing Z ^a   Chou, Chai Lin ^a   Fang, Edward ^a   Matsubara, Joanne A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN [1-40]; CRYOPYRIN; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G ANTIBODY; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; X LINKED INHIBITOR OF APOPTOSIS;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; MALE; MICROGLIA; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID BETA-PEPTIDES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INFLAMMASOMES; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MICROGLIA; PEPTIDE FRAGMENTS; RATS; RATS, LONG-EVANS; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RETINAL PIGMENT EPITHELIUM; UP-REGULATION;

EID: 84875661147     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10849     Document Type: Article

References (67)

1. The Eye Diseases Prevalence Research Group. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24:335-610.
3. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
4. Hogg RE, Stevenson MR, Chakravarthy U, Beirne RO, Anderson RS. Early features of AMD. Ophthalmology. 2007;114:1028.
5. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
6. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2002;109:1767-1779.
7. Yehoshua Z, Rosenfeld PJ, Albini TA. Current clinical trials in dry AMD and the definition of appropriate clinical outcome measures. Semin Ophthalmol. 2011;26:167-180.
8. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:11830-11835.
9. Bruban J, Glotin AL, Dinet V, et al. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell. 2009;8:162-177.
10. Walsh DT, Bresciani L, Saunders D, et al. Amyloid beta peptide causes chronic glial cell activation and neuro-degeneration after intravitreal injection. Neuropathol Appl Neurobiol. 2005;31: 491-502.
11. Dentchev T, Milam AH, Lee V, Trojanowski JQ, Dunaief JL. Amyloid-b is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 2003;9:184-190.
12. Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486-489.
13. Isas JM, Luibl V, Johnson LV, et al. Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci. 2010;51: 1304-1310.
14. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-b peptides differentially affect neuronal viability. J Biol Chem. 2002;277: 32046-32053.
15. Kurji KH, Cui JZ, Lin T, et al. Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-b stimulation of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2010;51:1151-1163.
16. Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9:857-865.
17. Tarallo V, Hirano Y, Gelfand B, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell. 2012;149:847-859.
18. Kauppinen A, Niskanen H, Suuronen T, Kinnunen K, Salminen A, Kaarniranta K. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol Lett. 2012;147:29-33.
19. Keller M, R̈uegg A, Werner S, Beer H. Active caspase-1 is a regulator of unconventional protein secretion. Cell. 2008;132: 818-831.
20. Nakazawa T, Kayama M, Ryu M, et al. Tumor necrosis factoralpha mediates photoreceptor death in a rodent model of retinal detachment. Invest Ophthalmol Vis Sci. 2011;52:1384-1391.
21. Howlett D, Bate S, Collier S, et al. Characterisation of amyloidinduced inflammatory responses in the rat retina. Exp Brain Res. 2011;214:185-197.
22. Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A. Weekly vaccination with copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res. 2008;33:1011-1013.
23. Pfizer. Efficacy, safety and tolerability study of RN6G in subjects with geographic atrophy secondary to age-related macular degeneration. ClinicalTrials. gov. 2012. Available at: http:// www.clinicaltrials.gov/ct2/show/NCT01577381. Accessed January 2, 2013.
24. Anderson P, Watts H, Hille C, et al. Glial and endothelial bloodretinal barrier responses to amyloid-b in the neural retina of the rat. Clin Ophthalmol. 2008;2:801-816.
25. Walsh DT, Montero RM, Bresciani LG, et al. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis. 2002;10:20-27.
26. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-b deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008;49:5136-5143.
27. Guo L, Normando EM, Nizari S, Lara D, Cordeiro MF. Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT. Invest Ophthalmol Vis Sci. 2010;51:6504-6513.
28. Davis D, Zhang A, Etienne C, Huang I, Malit M. Tech Note 2861: Principles of Curve Fitting for Multiplex Sandwich Immunoassays. Hercules, CA: Bio-Rad; 2012.
29. Hoh Kam J, Lenassi E, Jeffery G. Viewing ageing eyes: diverse sites of amyloid beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One. 2010;5: e13127.
30. Seddon JM, George S, Rosner B, Rifai N. Progression of agerelated macular degeneration: prospective assessment of Creactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005;123:774-782.
31. Bian Z, Elner SG, Yoshida A, Kunkel SL, Su J, Elner VM. Activation of p38, ERK1/2 and NIK pathways is required for IL-1b and TNFa-induced chemokine expression in human retinal pigment epithelial cells. Exp Eye Res. 2001;73:111-121.
32. Yoshida T, Ohno-Matsui K, Ichinose S, et al. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest. 2005;115:2793-2800.
33. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-b. Mol Cell. 2002;10:417-426.
34. Elner S, Elner V, Jaffe G, Stuart A, Kunkel S, Strieter R. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res. 1995;14:1045-1053.
35. Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116:87-93.
36. Wang J, Ohno-Matsui K, Yoshida T, et al. Amyloid-beta upregulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: another mechanism of complement activation in agerelated macular degeneration. J Cell Physiol. 2009;220:119-128.
37. Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One. 2009;4:e7945.
38. Rosenbaum DM, Degterev A, David J, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res. 2010;88:1569.
39. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
40. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
41. Mo FM, Proia AD, Johnson WH, Cyr D, Lashkari K. Interferon c-inducible protein-10 (IP-10) and eotaxin as biomarkers in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2010; 51:4226-4236.
42. Jiang K, To E, Cui J, Cao S, Gao J, Matsubara J. Drusen and proinflammatory mediators in the post-mortem human eye. J Clin Exp Ophthalmol. 2012;3:1-9.
43. Prakasam A, Muthuswamy A, Ablonczy Z, et al. Differential accumulation of secreted AbPP metabolites in ocular fluids. J Alzheimers Dis. 2010;20:1243-1253.
44. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20:29-48.
45. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res. 1993;12:205-212.
46. Nakazawa T, Matsubara A, Noda K, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006; 12:867-878.
47. Jaffe GJ, Van Le L, Valea F, et al. Expression of interleukin-1a, interleukin-1b, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res. 1992;55: 325-335.
48. Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokinestimulated human retinal pigment epithelial cells. Exp Eye Res. 1992;54:361-368.
49. Hangai M, Yoshimura N, Honda Y. Increased cytokine gene expression in rat retina following transient ischemia. Ophthalmic Res. 1996;28:248-254.
50. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14: 409-426.
51. Chen Y, Yang P, Li F, Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS One. 2011;6:e18139.
52. Doyle SL, Campbell M, Ozaki E, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med. 2012;18:791-798.
53. Bian ZM, Elner SG, Khanna H, Murga-Zamalloa CA, Patil S, Elner VM. Expression and functional roles of caspase-5 in inflammatory responses of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2011;52:8646-8656.
54. Yang P, McKay BS, Allen JB, Jaffe GJ. Effect of NF-jB inhibition on TNF-a-induced apoptosis in human RPE cells. Invest Ophthalmol Vis Sci. 2004;45:2438-2446.
55. Yang P, Peairs JJ, Tano R, Zhang N, Tyrell J, Jaffe GJ. Caspase-8-mediated apoptosis in human RPE cells. Invest Ophthalmol Vis Sci. 2007;48:3341-3349.
56. Dunaief JL, Dentchev T, Ying G, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002; 120:1435-1442.
57. Xia Y, Novak R, Lewis J, Duckett C, Phillips A. Xaf1 can cooperate with TNFa in the induction of apoptosis, independently of interaction with XIAP. Mol Cell Biochem. 2006;286:67-76.
58. Kempkensteffen C, Fritzsche FR, Johannsen M, et al. Downregulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer. 2009; 9:276.
59. Malek G, Johnson LV, Mace BE, et al. Apolipoprotein E alleledependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A. 2005;102:11900-11905.
60. Chan CC, Ross RJ, Shen D, et al. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 2008;40:124-128.
61. Ambati J, Anand A, Fernandez S, et al. An animal model of agerelated macular degeneration in senescent ccl-2-or ccr-2-deficient mice. Nat Med. 2003;9:1390-1397.
62. Chen M, Forrester JV, Xu H. Dysregulation in retinal parainflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS One. 2011;6:e22818.
63. Wang Y, Wang VM, Chan CC. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye. 2011;25:127-139.
64. Sanchez RN, Chan CK, Garg S, et al. Interleukin-6 in retinal ischemia reperfusion injury in rats. Invest Ophthalmol Vis Sci. 2003;44:4006-4011.
65. Peinnequin A, Mouret C, Birot O, et al. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004;5:3.
66. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation crosstalk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol. 2004;172: 4618-4623.
67. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods. 2000;98:9-20.